PrEP on the Rise

21 March 2017

Figures suggest increase in online sales

While the NHS is engaging in a further trial of the drug following the High Court ruling that affirmed its ability to offer Pre-Exposure Prophylaxis (PrEP), London has already seen a significant fall in HIV infections. Many organisations have suggested this is due to increased private online sales of the PrEP drug Truvada. Others are suggesting that a rise in gonorrhea and syphilis supports this pattern.